ID   TRIL_RAT                Reviewed;         811 AA.
AC   Q496Z2;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   24-JUL-2024, entry version 120.
DE   RecName: Full=TLR4 interactor with leucine rich repeats;
DE   AltName: Full=Leucine-rich repeat-containing protein KIAA0644 homolog;
DE   Flags: Precursor;
GN   Name=Tril;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=19710467; DOI=10.4049/jimmunol.0901518;
RA   Carpenter S., Carlson T., Dellacasagrande J., Garcia A., Gibbons S.,
RA   Hertzog P., Lyons A., Lin L.L., Lynch M., Monie T., Murphy C., Seidl K.J.,
RA   Wells C., Dunne A., O'Neill L.A.;
RT   "TRIL, a functional component of the TLR4 signaling complex, highly
RT   expressed in brain.";
RL   J. Immunol. 183:3989-3995(2009).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-798, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Component of the TLR4 signaling complex. Mediates the innate
CC       immune response to bacterial lipopolysaccharide (LPS) leading to
CC       cytokine secretion and the inflammatory response (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Belongs to the lipopolysaccharide (LPS) receptor, a multi-
CC       protein complex containing at least CD14, MD-2 and TLR4. Interacts with
CC       TLR4; this interaction is greatly enhanced following LPS stimulation
CC       (By similarity). Interacts with LPS (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in cortical astrocytes and in
CC       cerebellar granule neurons. {ECO:0000269|PubMed:19710467}.
CC   -!- PTM: N-glycolysaled. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC100659; AAI00660.1; -; mRNA.
DR   RefSeq; NP_001029182.1; NM_001034010.1.
DR   AlphaFoldDB; Q496Z2; -.
DR   SMR; Q496Z2; -.
DR   STRING; 10116.ENSRNOP00000037327; -.
DR   GlyCosmos; Q496Z2; 3 sites, No reported glycans.
DR   GlyGen; Q496Z2; 3 sites.
DR   iPTMnet; Q496Z2; -.
DR   PhosphoSitePlus; Q496Z2; -.
DR   PaxDb; 10116-ENSRNOP00000037327; -.
DR   Ensembl; ENSRNOT00000036951.3; ENSRNOP00000037327.1; ENSRNOG00000026941.3.
DR   Ensembl; ENSRNOT00065020120; ENSRNOP00065015437; ENSRNOG00065012358.
DR   GeneID; 362364; -.
DR   KEGG; rno:362364; -.
DR   UCSC; RGD:1310827; rat.
DR   AGR; RGD:1310827; -.
DR   CTD; 9865; -.
DR   RGD; 1310827; Tril.
DR   eggNOG; KOG0619; Eukaryota.
DR   GeneTree; ENSGT00940000161975; -.
DR   HOGENOM; CLU_357128_0_0_1; -.
DR   InParanoid; Q496Z2; -.
DR   OMA; PHDVLTY; -.
DR   OrthoDB; 4599366at2759; -.
DR   PhylomeDB; Q496Z2; -.
DR   TreeFam; TF331598; -.
DR   PRO; PR:Q496Z2; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000026941; Expressed in Ammon's horn and 19 other cell types or tissues.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0046696; C:lipopolysaccharide receptor complex; ISO:RGD.
DR   GO; GO:0001530; F:lipopolysaccharide binding; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0002718; P:regulation of cytokine production involved in immune response; ISO:RGD.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; ISO:RGD.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR050541; LRR_TM_domain-containing.
DR   PANTHER; PTHR24369; ANTIGEN BSP, PUTATIVE-RELATED; 1.
DR   PANTHER; PTHR24369:SF210; CHAOPTIN-RELATED; 1.
DR   Pfam; PF13855; LRR_8; 4.
DR   SMART; SM00369; LRR_TYP; 11.
DR   SUPFAM; SSF49265; Fibronectin type III; 1.
DR   SUPFAM; SSF52058; L domain-like; 1.
DR   PROSITE; PS51450; LRR; 13.
PE   1: Evidence at protein level;
KW   Glycoprotein; Immunity; Inflammatory response; Innate immunity;
KW   Leucine-rich repeat; Membrane; Phosphoprotein; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..811
FT                   /note="TLR4 interactor with leucine rich repeats"
FT                   /id="PRO_0000349257"
FT   TOPO_DOM        26..696
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        697..717
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        718..809
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          26..57
FT                   /note="LRRNT"
FT   REPEAT          61..81
FT                   /note="LRR 1"
FT   REPEAT          84..105
FT                   /note="LRR 2"
FT   REPEAT          108..129
FT                   /note="LRR 3"
FT   REPEAT          132..153
FT                   /note="LRR 4"
FT   REPEAT          156..177
FT                   /note="LRR 5"
FT   REPEAT          180..201
FT                   /note="LRR 6"
FT   REPEAT          204..223
FT                   /note="LRR 7"
FT   REPEAT          230..251
FT                   /note="LRR 8"
FT   REPEAT          254..275
FT                   /note="LRR 9"
FT   REPEAT          278..298
FT                   /note="LRR 10"
FT   REPEAT          302..323
FT                   /note="LRR 11"
FT   REPEAT          326..347
FT                   /note="LRR 12"
FT   DOMAIN          359..416
FT                   /note="LRRCT"
FT   REGION          414..460
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          486..562
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        414..429
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        490..504
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        524..562
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         798
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        411
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        589
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   811 AA;  89053 MW;  2913EFA8BBFBB355 CRC64;
     MEGVGAVRFW LVVCGCLAFP PRAESVCPER CDCQHPQHLL CTNRGLRAVP KTSSLPSPQD
     VLTYSLGGNF ITNITAFDFH RLGQLRRLDL QYNQIRSLHP KTFEKLSRLE ELYLGNNLLQ
     ALAPGTLAPL RKLRILYANG NEIGRLSRGS FEGLESLVKL RLDGNVLGAL PDAVFAPLGN
     LLYLHLEANR IRFLGKNAFT QLGKLRFLNL SANELQPSLR HAATFVPLRS LSTLILSANS
     LQHLGPRVFQ HLPRLGLLSL SGNQLTHLAP EAFWGLEALR ELRLEGNRLN QLPLTLLEPL
     HSLEALDLSG NELSALHPAT FGHQGRLREL SLRDNALSAL SGDIFAASPA LYRLDLDGNG
     WTCDCRLRGL KRWMGNWHSQ GRLLTVFVQC RHPPALRGKY LDYLDDQLLQ NGSCVDPSPS
     PTAGSRQWPI STAPGEGMTP PAGLAQELPL QPQPQPQQRG RLLPGVAWAG AAKELVGNRS
     ALRLNRRGPG LQHQSPSAAA ASGSAPQSLD LHEKPERGRP TRANLPQTEP TPTSEPASGT
     PSARDSWQRA AKQRLASEQQ GRAVQYDSGV GLPPLVSDPC DFNKFILCNL TVEAVSANSA
     SVRWAVREHR SPRPQGGARF RLLFDRFGQQ PKFQRFVYLP ERSDSATLHE LRGDTPYLVC
     VEGVLGGRVC PVAPRDHCAG LVTLPEAGGR GGVDYQLLTL VLLAINALLV LLALAAWGSR
     WLRRKLRARR KGGAPVHVRH MYSTRRPLRS MGTGVSADFS GFQSHRPRTT VCALSEADLI
     EFPCDRFMDS SGGGTGGSLR REDHLLQRFA D
//
